Clemett D - Search Results

1

A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.

LoRusso PM, Infante JR, Kim KB, Burris HA 3rd, Curt G, Emeribe U, Clemett D, Tomkinson HK, Cohen RB. LoRusso PM, et al. Among authors: clemett d. BMC Cancer. 2017 Mar 6;17(1):173. doi: 10.1186/s12885-017-3143-6. BMC Cancer. 2017. PMID: 28264648 Free PMC article. Clinical Trial.

2

A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.

Infante JR, Cohen RB, Kim KB, Burris HA 3rd, Curt G, Emeribe U, Clemett D, Tomkinson HK, LoRusso PM. Infante JR, et al. Among authors: clemett d. Invest New Drugs. 2017 Oct;35(5):576-588. doi: 10.1007/s10637-017-0459-7. Epub 2017 Apr 19. Invest New Drugs. 2017. PMID: 28424891 Free PMC article. Clinical Trial.

3

Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.

Infante JR, Cohen RB, Kim KB, Burris HA 3rd, Curt G, Emeribe U, Clemett D, Tomkinson HK, LoRusso PM. Infante JR, et al. Among authors: clemett d. Invest New Drugs. 2017 Oct;35(5):669. doi: 10.1007/s10637-017-0479-3. Invest New Drugs. 2017. PMID: 28676972 Free PMC article. No abstract available.

4

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).

Carvajal RD, Piperno-Neumann S, Kapiteijn E, Chapman PB, Frank S, Joshua AM, Piulats JM, Wolter P, Cocquyt V, Chmielowski B, Evans TRJ, Gastaud L, Linette G, Berking C, Schachter J, Rodrigues MJ, Shoushtari AN, Clemett D, Ghiorghiu D, Mariani G, Spratt S, Lovick S, Barker P, Kilgour E, Lai Z, Schwartz GK, Nathan P. Carvajal RD, et al. Among authors: clemett d. J Clin Oncol. 2018 Apr 20;36(12):1232-1239. doi: 10.1200/JCO.2017.74.1090. Epub 2018 Mar 12. J Clin Oncol. 2018. PMID: 29528792 Free article. Clinical Trial.

5

Exemestane: a review of its use in postmenopausal women with advanced breast cancer.

Clemett D, Lamb HM. Clemett D, et al. Drugs. 2000 Jun;59(6):1279-96. doi: 10.2165/00003495-200059060-00007. Drugs. 2000. PMID: 10882163 Review.

6

Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.

Culy CR, Clemett D, Wiseman LR. Culy CR, et al. Among authors: clemett d. Drugs. 2000 Oct;60(4):895-924. doi: 10.2165/00003495-200060040-00005. Drugs. 2000. PMID: 11085200 Review.

7

Raloxifene: a review of its use in postmenopausal osteoporosis.

Clemett D, Spencer CM. Clemett D, et al. Drugs. 2000 Aug;60(2):379-411. doi: 10.2165/00003495-200060020-00013. Drugs. 2000. PMID: 10983739 Review.

8

Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.

Clemett D, Markham A. Clemett D, et al. Drugs. 2000 Apr;59(4):929-56. doi: 10.2165/00003495-200059040-00016. Drugs. 2000. PMID: 10804042 Review.

9

Linezolid.

Clemett D, Markham A. Clemett D, et al. Drugs. 2000 Apr;59(4):815-27; discussion 828. doi: 10.2165/00003495-200059040-00007. Drugs. 2000. PMID: 10804037 Review.

10

Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.

Clemett D, Goa KL. Clemett D, et al. Drugs. 2000 Apr;59(4):957-80. doi: 10.2165/00003495-200059040-00017. Drugs. 2000. PMID: 10804043 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page